Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Celgene Corporation (CELG)

93.42   -0.34 (-0.36%) 04-22 16:00
Open: 93.7 Pre. Close: 93.76
High: 94.05 Low: 93.205
Volume: 5,837,398 Market Cap: 65623M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 94.191 - 94.849 94.849 - 95.354
Low: 91.46 - 92.367 92.367 - 93.064
Close: 92.175 - 93.393 93.393 - 94.329

Technical analysis

as of: 2019-04-22 4:25:10 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 111.47     One year: 130.20
Support: Support1: 89.74    Support2: 86.21
Resistance: Resistance1: 95.44    Resistance2: 111.47
Pivot: 94.21
Moving Average: MA(5): 94.23     MA(20): 93.04
MA(100): 83.71     MA(250): 83.42
MACD: MACD(12,26): 1.43     Signal(9): 1.64
Stochastic oscillator: %K(14,3): 49.40     %D(3): 72.52
RSI: RSI(14): 56.12
52-week: High: 95.44  Low: 58.59  Change(%): 4.4
Average Vol(K): 3-Month: 1006516  10-Days: 853403

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CELG has closed above bottom band by 10.8%. Bollinger Bands are 83.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to CELG's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 20 Apr 2019 22:07:02 Z
How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results

Wed, 17 Apr 2019 17:10:51 Z
iShares Nasdaq Biotechnology ETF Experiences Big Outflow

Wed, 17 Apr 2019 14:12:36 Z
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal

Wed, 17 Apr 2019 03:07:06 Z
Is TG Therapeutics a Buy?

Tue, 16 Apr 2019 19:07:59 Z
Why Amgen Stock Could Break Out to New Highs

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 702.36
Shares Float (M) 698.56
% Held by Insiders 0.50
% Held by Institutions 114.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 7.700
EPS Est. Current Year 7.320
EPS Est. Next Year 8.810
EPS Est. Next Quarter 2.030
Forward EPS 10.163
Book Value (p.s.) 10.740
PEG Ratio 0.49
Profit Margin 27.27
Operating Margin 35.92
Return on Assets (ttm) 12.3
Return on Equity (ttm) 61.9
Qtrly Rev. Growth 15.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 5170.00
Levered Free Cash Flow (M) 4820.00

Stock Valuations

P/E 12.13
P/E Growth Ratio
P/BV 8.70
P/S 3076158976.00
P/CF 12.69

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-06-26
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.